Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | Director | August 10, 2026 | August 11, 2026 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,802 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Purchase · Acquired 5,000 · Balance 31,802 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 197,728 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 197,728 · Balance 197,728 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,791 | $168.80 | $977,497.64 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,077 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F6 · price: Represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,916 | $167.70 | $824,433.85 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685,868 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F5 · price: Represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,899 | $166.73 | $650,093.14 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,784 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F4 · price: Represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,600 | $165.60 | $264,962.08 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,683 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F3 · price: Represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,933 | $6.01 | $11,617.33 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 23,067 | $1.67 | $38,521.89 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Read SEC document |
| May 05, 2020 Filed May 11, 2020 10:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-20-005666 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,067 Underlying: Common Stock · 20,000 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| May 05, 2020 Filed May 11, 2020 10:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 40,000 | $170.26 | $6,810,400.00 |
DisclosureSEC source: 0001179110-20-005666 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $167.73 to $176.57. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2020 Filed May 11, 2020 10:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,000 | $1.67 | $33,400.00 |
DisclosureSEC source: 0001179110-20-005666 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 16,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,555 Underlying: Common Stock · 16,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 21,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,621 Underlying: Common Stock · 21,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020. F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 8,065 | $132.73 | $1,070,467.45 |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,493 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 16,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 10,486 | $132.73 | $1,391,806.78 |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672,778 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 21,812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003225 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2020 Filed Feb 10, 2021 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,188 Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 6,446 | $125.30 | $807,683.80 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,452 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 27,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,311 Underlying: Common Stock · 27,311 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 13,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,944 Underlying: Common Stock · 13,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three annual installments beginning on March 4, 2019 and March 1 each subsequent year. F7 · derivative.expiration_date: On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three annual installments beginning on March 4, 2019 and March 1 each subsequent year. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 13,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281 Underlying: Common Stock · 13,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 7,260 | $124.32 | $902,563.20 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,398 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 6,492 | $124.32 | $807,085.44 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,712 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:28 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 65,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002580 · edgar.xml · derivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,433 Underlying: Common Stock · 65,433 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| December 26, 2019 Filed Feb 12, 2020 21:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001513 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,924 Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,639 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,067 Underlying: Common Stock · 4,639 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,361 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,361 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested in 30 equal monthly installments thereafter. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,639 | $1.67 | $7,747.13 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,361 | $1.67 | $8,952.87 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-006365 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,706 Underlying: Common Stock · 20,000 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 20,000 | $61.17 | $1,223,400.00 |
DisclosureSEC source: 0001179110-19-006365 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,924 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $59.00 to $62.32. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,000 | $1.67 | $33,400.00 |
DisclosureSEC source: 0001179110-19-006365 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 12:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-005098 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,361 Underlying: Common Stock · 30,000 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested in 30 equal monthly installments thereafter. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 12:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $53.04 | $1,591,200.00 |
DisclosureSEC source: 0001179110-19-005098 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,924 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $52.35 to $54.51. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 12:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $1.67 | $50,100.00 |
DisclosureSEC source: 0001179110-19-005098 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 673,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,161 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-004353 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,839 Underlying: Common Stock · 8,161 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,912 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-004353 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,706 Underlying: Common Stock · 11,912 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,161 | $12.21 | $99,645.81 |
DisclosureSEC source: 0001179110-19-004353 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 20:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 11,912 | $1.67 | $19,893.04 |
DisclosureSEC source: 0001179110-19-004353 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-004143 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,361 Underlying: Common Stock · 30,000 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested in 30 equal monthly installments thereafter. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $63.16 | $1,894,800.00 |
DisclosureSEC source: 0001179110-19-004143 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,851 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $62.53 to $63.69. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $1.67 | $50,100.00 |
DisclosureSEC source: 0001179110-19-004143 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Feb 12, 2020 21:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001513 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,924 Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 6,192 | $60.62 | $375,359.04 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,192 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 27,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,890 Underlying: Common Stock · 27,890 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F7 · derivative.exercise_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.